Ann: Proposed IPO of China Subsidiary in Hong Kong, page-260

The push down was the only way the big boys were going to be able to accumulate decent parcel of shares and I have no problem with that because I got to benefit from buying more as well, along with many others on here I suspect.

My predication is CFDA will come in the month of September.

Prizma production and MOU sales is just a matter of time, along with FDA approval of patch and CFDA approval.

I'm looking forward to the next lot of products they bring to the market and for the HK IPO
Will it be COPD, diabetics, sleep apnea or something along the lines that will help streamline hospital patient records/id for insurance companies or help with the streamline/distribution/ reminder of medication?

CFDA for the prizma will see a 20 year idea for Yacov, turn into reality.

He has worked extremely hard bringing this to market, along with his management team and their vision will reap the rewards in not too distance future.